Le Lézard
Classified in: Health, Business
Subjects: SVY, LIC, CSR, STP

My Patient Rights Urges Californians to Use Holiday Gatherings to Discuss New Tools Available to Combat Opioid Crisis in 2019


SACRAMENTO, Calif., Dec. 11, 2018 /PRNewswire/ -- My Patient Rights and the California Chronic Care Coalition are urging California families to use visiting with family members during the holidays to make sure that they are aware of a new law taking effect in January 2019. The new law addresses the opioid crisis by requiring prescribers of pain-relieving opioids to also offer a prescription for the opioid-overdose reversal drug, naloxone to high-risk patients. AB 2760 was passed overwhelmingly by the California Legislature and signed into law in September 2018 by Gov. Edmund G. Brown, Jr.

California Chronic Care Coalition/My Patient Rights (PRNewsfoto/California Chronic Care Coaliti)

Accidental opioid overdoses account for about 80 percent of all opioid emergencies and 83 percent of prescription opioid-related deaths are unintended or accidental. While anyone taking opioids is at potential risk for an overdose, there are certain high-level, at-risk groups that are susceptible, so being prepared with the overdose reversal drug, naloxone, in close proximity is essential.

This problem has become so acute that the U.S. Surgeon General issued its first advisory in 13 years recommending emergency treatments like naloxone ? which is so important to saving lives ? be available for consumer use.

"For patients with chronic illness, pain relieving opioids are a lifeline but the risk of an overdose increases the more you take to combat the pain," said Liz Helms, president and CEO of the California Chronic Care Coalition. "Requiring naloxone to be offered at the same time as prescribing an opioid pain medication will go a long way in preventing accidental overdoses and needless deaths. And since many caregivers are family members, having the conversation over the holidays will ensure that everyone is aware of the availability of this potentially life-saving emergency treatment."

There are many reasons for accidental opioid overdose emergencies and these emergencies can occur even when opioids are used as directed. Those at high risk for accidental opioid overdose include:

In 2016, more than 214 million prescriptions were written and filled for opioids. With this many patients taking opioids for medical conditions and medical procedures, it's important to have the discussion and prepare for potential overdoses.

"Naloxone is a tool that can immediately save lives. And I hope this new law will provide an opportunity for discussion of the potential for accidental opioid overdose and how to prevent it," said Assemblymember Jim Wood (D-Santa Rosa), author of AB 2760.

Anyone who uses opioids for pain control is at risk for an opioid overdose emergency. When you are together with family this holiday season, make sure you and your families are prepared for the unexpected by talking about opioids, the potential for overdose even when used correctly, having naloxone with you, and recognizing the signs of overdose:

Knowing the risks, recognizing the signs and having naloxone on-hand will go a long way in potentially saving a life from accidental opioid overdose.

About My Patient Rights
My Patient Rights was launched by the California Chronic Care Coalition to help people who have been denied treatment or medicines, experienced delays or are dissatisfied with the decisions made by their health plan.

About California Chronic Care Coalition
The California Chronic Care Coalition (CCCC) is a unique alliance of more than thirty leading consumer health organizations and provider groups that engage policy makers, industry leaders, providers and consumers to improve the health of Californians with chronic conditions. We envision a system of care that is accessible, affordable and of a high quality that emphasizes prevention, coordinated care and the patient's wellness and longevity.

 

SOURCE My Patient Rights


These press releases may also interest you

at 21:29
TSX VENTURE COMPANIES BULLETIN V2024-1211 ALPHAMIN RESOURCES CORP.  ("AFM")BULLETIN TYPE:  Declaration of DividendBULLETIN DATE:  April 26, 2024TSX Venture Tier 2 Company The Issuer has declared the following dividend: Dividend Amount per Common...

at 21:22
Wall Financial Corporation (the "Company") released its operating results and financial statements for the three months and year  ended January 31, 2024.  The Company recorded net earnings and comprehensive income attributable to shareholders of the...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 20:39
Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New...

at 20:15
The partnership was unveiled internally at the Franchisor's annual convention in Las Vegas, NV in December 2023, eliciting...

at 19:35
Regenx Tech Corp., (the "Company" or "Regenx") is providing this bi-weekly update on the status of the application to the Alberta Securities Commission for a management cease trade order, under National Policy 12-203 -?? Management Cease Trade...



News published on and distributed by: